635 related articles for article (PubMed ID: 30134963)
1. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
3. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
[TBL] [Abstract][Full Text] [Related]
4. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
5. The Ankle-Brachial Index Is Associated with Cerebral β-Amyloid Deposition in Cognitively Normal Older Adults.
Moon SW; Byun MS; Yi D; Lee JH; Jeon SY; Lee Y; Kee BS; Lee DY;
J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1141-1148. PubMed ID: 29982493
[TBL] [Abstract][Full Text] [Related]
6. The effect of β-amyloid positivity on cerebral metabolism in cognitively normal seniors.
Bozoki AC; Zdanukiewicz M; Zhu DC;
Alzheimers Dement; 2016 Dec; 12(12):1250-1258. PubMed ID: 27445158
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging.
Jagust WJ; Landau SM;
J Neurosci; 2012 Dec; 32(50):18227-33. PubMed ID: 23238736
[TBL] [Abstract][Full Text] [Related]
8. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
[TBL] [Abstract][Full Text] [Related]
9. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
[TBL] [Abstract][Full Text] [Related]
10. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
11. Associations of thyroid hormone serum levels with in-vivo Alzheimer's disease pathologies.
Choi HJ; Byun MS; Yi D; Sohn BK; Lee JH; Lee JY; Kim YK; Lee DY;
Alzheimers Res Ther; 2017 Aug; 9(1):64. PubMed ID: 28818092
[TBL] [Abstract][Full Text] [Related]
12. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
Pardo JV; Lee JT;
eNeuro; 2018; 5(1):. PubMed ID: 29497704
[TBL] [Abstract][Full Text] [Related]
13. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
Mosconi L; Rinne JO; Tsui WH; Berti V; Li Y; Wang H; Murray J; Scheinin N; Någren K; Williams S; Glodzik L; De Santi S; Vallabhajosula S; de Leon MJ
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5949-54. PubMed ID: 20231448
[TBL] [Abstract][Full Text] [Related]
14. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
Reiman EM; Chen K; Liu X; Bandy D; Yu M; Lee W; Ayutyanont N; Keppler J; Reeder SA; Langbaum JB; Alexander GE; Klunk WE; Mathis CA; Price JC; Aizenstein HJ; DeKosky ST; Caselli RJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6820-5. PubMed ID: 19346482
[TBL] [Abstract][Full Text] [Related]
15. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
[TBL] [Abstract][Full Text] [Related]
16. Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.
Duarte-Abritta B; Villarreal MF; Abulafia C; Loewenstein D; Curiel Cid RE; Castro MN; Surace E; Sánchez SM; Vigo DE; Vázquez S; Nemeroff CB; Sevlever G; Guinjoan SM
J Psychiatr Res; 2018 Dec; 107():11-18. PubMed ID: 30308328
[TBL] [Abstract][Full Text] [Related]
17. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.
Mosconi L; Brys M; Switalski R; Mistur R; Glodzik L; Pirraglia E; Tsui W; De Santi S; de Leon MJ
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19067-72. PubMed ID: 18003925
[TBL] [Abstract][Full Text] [Related]
18. Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.
Carbonell F; Zijdenbos AP; Bedell BJ;
J Alzheimers Dis; 2020; 73(2):543-557. PubMed ID: 31796668
[TBL] [Abstract][Full Text] [Related]
19. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
[TBL] [Abstract][Full Text] [Related]
20. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
